Serial analysis of gene expression showed that upregulation of ANXA2 activates RPS6KA1, a downstream component of the MAPK signaling pathway, thereby affecting the development and progression of gallbladder cancer [18]. The gene discussed is RPS6KA1; the disease is gallbladder cancer.